Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac®) and a proprietary 0.025% tretinoin gel formulation (Aberela®) in the topical control of facial acne
- 1 November 1998
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 11 (3) , 227-233
- https://doi.org/10.1016/s0926-9959(98)00071-3
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: